EU Court Backs Illumina Grail Deal
This is a Illumina news story, published by Yahoo Finance, that relates primarily to Grail news.
Illumina news
For more Illumina news, you can click here:
more Illumina newsGrail news
For more Grail news, you can click here:
more Grail newsdrug discoveries news
For more drug discoveries news, you can click here:
more drug discoveries newsYahoo Finance news
For more news from Yahoo Finance, you can click here:
more news from Yahoo FinanceAbout the Otherweb
Otherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like drug discoveries news, you might also like this article about
European Commission. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest General Court news, diagnostic test maker Grail news, drug discoveries news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
EU merger revenue thresholdReuters
•EU top court backs Illumina fight against EU probe into Grail deal
79% Informative
Europe 's top court backs U.S. gene sequencing company Illumina 's fight against EU antitrust regulators' investigation into its $7.1 billion bid for cancer diagnostic test maker Grail .
The General Court had in 2022 ruled in favour of the European Commission .
Illumina founded Grail and spun it off in 2016 only to re-acquire it in 2021 .
VR Score
90
Informative language
98
Neutral language
45
Article tone
formal
Language
English
Language complexity
58
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
short-lived
External references
no external sources
Source diversity
no sources
Affiliate links
no affiliate links